KRAS is one of the most frequently mutated oncogenes in CRC, and mutant KRAS oncoprotein can activate downstream RAF/MEK/ERK and PI3K/AKT signals, which are responsible for cancer cell proliferation, survival, and evasion of apoptosis. The gene discussed is MAP2K7; the disease is cancer.